Structural Insight into Interaction between C20 Phenylalanyl Derivative of Tylosin and Ribosomal Tunnel

Area of Science:

• Biochemistry
• Molecular Biology
• Microbiology

Background:

• Macrolide antibiotics, like tylosin, are crucial for inhibiting bacterial protein biosynthesis by targeting ribosomal function.
• Tylosin's activity relies on its aldehyde group's interaction with 23S ribosomal RNA, with modifications typically reducing efficacy.
• Previously synthesized tylosin derivatives showed potent activity despite aldehyde group substitution, necessitating structural investigation.

Purpose of the Study:

• To elucidate the molecular mechanism behind the high inhibitory activity of a specific tylosin derivative.
• To understand the structural basis of the interaction between the tylosin derivative and the bacterial ribosome.

Main Methods:

• Utilized molecular dynamics simulations to model the complex of the tylosin derivative with the E. coli ribosome.
• Focused on the interaction within the ribosomal tunnel, specifically involving the modified tylosin structure.

Main Results:

• Identified the precise structural arrangement of a tylosin derivative, featuring an ethyl ester of 2-imino(oxy)acetylphenylalanine at position 20, within the E. coli ribosome tunnel.
• The simulation data provided a structural explanation for the observed high biological activity of this modified macrolide.

Conclusions:

• The specific substitution in the tylosin derivative does not impede its binding to the ribosome.
• Molecular dynamics simulations are effective in explaining the mechanism of action for novel antibiotic derivatives.
• This research offers insights into designing new macrolide antibiotics with enhanced efficacy.